pirinixic acid has been researched along with benzoxazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryant, D; Bugelski, P; Camilleri, P; Cutler, P; Hayes, W; Holbrook, JD; Kramer, K; Lord, PG; Man, WJ; White, IR; Wood, J | 1 |
| Han, SI; Iwasaki, H; Matsuzaka, T; Murayama, Y; Nakagawa, Y; Ohno, H; Oikawa, F; Osaki, Y; Satoh, A; Sekiya, M; Shimano, H; Suzuki, H; Takei, K; Yahagi, N; Yamada, N; Yatoh, S | 1 |
2 other study(ies) available for pirinixic acid and benzoxazoles
| Article | Year |
|---|---|
Protein expression changes in the Sprague Dawley rat liver proteome following administration of peroxisome proliferator activated receptor alpha and gamma ligands.
Topics: Animals; Benzoxazoles; Chromans; Electrophoresis, Gel, Two-Dimensional; Gene Expression Regulation; Ligands; Liver; Male; Peroxisome Proliferators; Proteome; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Spectrometry, Mass, Electrospray Ionization; Thiazolidinediones; Transcription Factors; Troglitazone | 2003 |
Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
Topics: Animals; Benzoxazoles; Butyrates; Cell Line; Drug Evaluation, Preclinical; Fenofibrate; Gene Expression; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; PPAR alpha; Pyrimidines; X-Box Binding Protein 1 | 2017 |